# Trima Pharmaceutical Products > Israeli pharmaceutical company **Wikidata**: [Q106620053](https://www.wikidata.org/wiki/Q106620053) **Source**: https://4ort.xyz/entity/trima-pharmaceutical-products ## Summary Trima Pharmaceutical Products is an Israeli pharmaceutical company operating within the global pharmaceutical industry. Founded in 1941 by Chaim Weizmann, the enterprise is legally structured as a public company with its headquarters located in Ma'abarot, Israel. It offers its securities to the general public and maintains a digital presence via its official website. ## Key Facts * Trima Pharmaceutical Products is an Israeli public company operating within the pharmaceutical industry. * The company was founded in 1941 by Chaim Weizmann. * Its corporate headquarters are located in Ma'abarot, Israel. * The organization's official website is https://www.trima.co.il/. * It is legally classified as a "public company" (also known as a publicly traded or listed company), a joint-stock company structure distinct from private or state-owned enterprises. * The inception date of 1941 is corroborated by records from CheckID. * The company is tracked under the Crunchbase organization identifier "trima". * It is indexed in the National Library of Israel under the J9U ID 987007400797605171. * The entity has a sitelink count of 1, corresponding to its Hebrew Wikipedia page ("he"). ## FAQs **What is Trima Pharmaceutical Products?** It is an Israeli pharmaceutical company that operates as a publicly traded enterprise. Founded in 1941, it is based in the Ma'abarot region of Israel and maintains an official web presence. **Who founded the company and when did it start?** The organization was founded by Chaim Weizmann in the year 1941. This historical inception date is verified by specific corporate registry references. **What does it mean that Trima is a "public company"?** Operating as a public company means Trima offers its securities, such as stocks or bonds, to the general public, typically facilitating investment through a stock exchange. This structure broadens its capital pool beyond private investors, distributing ownership among general public shareholders while distinguishing it from state-owned public enterprises. ## Why It Matters Trima Pharmaceutical Products represents a historically significant component of Israel's corporate and pharmaceutical landscape, with a history spanning back to the early 1940s. Its classification as a public company is fundamental to its role in the economy; by offering securities to the general public, it facilitates large-scale capital formation and provides liquidity for investors. This corporate structure promotes transparency through required regulatory disclosures while driving industrial activity within the pharmaceutical sector. Founded by a prominent historical figure, Chaim Weizmann, the company's endurance highlights its sustained relevance in providing pharmaceutical products and maintaining a structured, publicly accountable business model. ## Notable For * Being an early Israeli enterprise in the pharmaceutical industry, established in 1941. * Having been founded by Chaim Weizmann, a prominent historical figure. * Operating as a publicly traded entity, a structure that allows general public shareholders to own stakes in the business. * Maintaining its headquarters in Ma'abarot since its mid-20th-century inception. ## Body ### Corporate Profile and Identification Trima Pharmaceutical Products is an enterprise operating within the pharmaceutical industry, distinctly classified as both a standard company and a public company. The organization is officially based in Israel, with its headquarters situated in the town of Ma'abarot. Its primary digital identity is hosted at https://www.trima.co.il/. The company's public identity is tracked and verified through several major knowledge bases and institutional registries, including a Crunchbase organization ID ("trima") and a dedicated National Library of Israel J9U identifier (987007400797605171). ### History and Founding The inception of Trima Pharmaceutical Products dates back to 1941. The company was founded by Chaim Weizmann. The 1941 establishment date is supported by external corporate tracking references, specifically through CheckID. The company's historical footprint is primarily documented in Hebrew-language resources, reflected by its presence on Hebrew Wikipedia ("he") and a total sitelink count of 1 in major knowledge bases. ### Legal Structure and Public Market Status As a public company, Trima Pharmaceutical Products operates as a specific legal form of a joint-stock company. This classification dictates that the company's ownership is distributed among general public shareholders rather than being held privately or by the state. By offering its securities for sale to the general public, the company can raise capital from a wide pool of investors. This legal form requires adherence to strict regulatory disclosure and reporting standards, promoting transparency for its investors. Governance is typically provided by a board of directors elected by the shareholders, establishing a classic corporate separation between ownership (the public shareholders) and operational control (management). This structure fundamentally differentiates Trima from private companies, cooperatives, or government-owned public enterprises. ## References 1. [Source](https://www.checkid.co.il/company/%D7%AA%D7%A8%D7%99%D7%9E%D7%94-%D7%AA%D7%95%D7%A6%D7%A8%D7%99-%D7%A8%D7%A4%D7%95%D7%90%D7%94-%D7%99%D7%A9%D7%A8%D7%90%D7%9C%D7%99%D7%99%D7%9D-%D7%9E%D7%A2%D7%91%D7%A8%D7%95%D7%AA-%D7%91%D7%A2~%D7%9E-510008402)